| [1] |
|
| [2] |
Kawa S， Ota M， Yoshizawa K，et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population[J]. Gastroenterology， 2002， 122（5）：1264-1269. DOI： 10.1053/gast.2002.33022.
|
| [3] |
Culver EL， Hurst JM， Cargill T，et al. Human leucocyte antigen associations in IgG4-related disease and primary sclerosing cholangitis stratified by IgG4 levels，in a Multicenter UK Cohort[J]. J Hepatology， 2016， 64（2）：S646. DOI： 10.1016/s0168-8278(16)01205-8.
|
| [4] |
Mattoo H， Mahajan VS， Della-Torre E，et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease[J]. J Allergy Clin Immunol， 2014， 134（3）：679-687. DOI： 10.1016/j.jaci.2014.03.034.
|
| [5] |
Lanzillotta M， Mancuso G， Della-Torre E. Advances in the diagnosis and management of IgG4 related disease[J]. BMJ， 2020， 369：m1067. DOI： 10.1136/bmj.m1067.
|
| [6] |
Michailidou D， Schwartz DM， Mustelin T，et al. Allergic aspects of IgG4-related disease：Implications for pathogenesis and therapy[J]. Front Immunol， 2021， 12：693192. DOI： 10.3389/fimmu.2021.693192.
|
| [7] |
Kubo S， Nakayamada S， Zhao J，et al. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease[J]. Rheumatology（Oxford）， 2018， 57（3）：514-524. DOI： 10.1093/rheumatology/kex455.
|
| [8] |
Maehara T， Mattoo H， Ohta M，et al. Lesional CD4 + IFN-γ + cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis[J]. Ann Rheum Dis， 2017， 76（2）：377-385. DOI： 10.1136/annrheumdis-2016-209139.
|
| [9] |
Yoshikawa T， Watanabe T， Minaga K，et al. Cytokines produced by innate immune cells in IgG4-related disease[J]. Mod Rheumatol， 2019， 29（2）：219-225. DOI： 10.1080/14397595.2018.1536364.
|
| [10] |
Umehara H， Okazaki K， Kawano M，et al. The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease？[J]. Mod Rheumatol， 2019， 29（2）：214-218. DOI： 10.1080/14397595.2018.1558519.
|
| [11] |
Du H， Shi L， Chen P，et al. Prohibitin is involved in patients with IgG4 related disease[J]. PloS One， 2015， 10（5）：e0125331. DOI： 10.1371/journal.pone.0125331.
|
| [12] |
Hubers LM， Vos H， Schuurman AR，et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease[J]. Gut， 2018， 67（4）：728-735. DOI： 10.1136/gutjnl-2017-314548.
|
| [13] |
Kountouras J， Zavos C， Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis[J]. J Cell Mol Med， 2005， 9（1）：196-207. DOI： 10.1111/j.1582-4934.2005.tb00349.x.
|
| [14] |
Frulloni L， Lunardi C， Simone R，et al. Identification of a novel antibody associated with autoimmune pancreatitis[J]. N Engl J Med， 2009， 361（22）：2135-2142. DOI： 10.1056/NEJMoa0903068.
|
| [15] |
Onishi Y， Nakahara Y， Hirano K，et al. IgG4-related disease in asbestos-related pleural disease[J]. Respirol Case Rep， 2015， 4（1）：22-24. DOI： 10.1002/rcr2.142.
|
| [16] |
Otsuki T，Maeda M，Murakami S，et al. Immunological effects of silica and asbestos[J]. Cell Mol Immunol，2007，4（4）：261-268.
|
| [17] |
Wallace ZS， Zhang Y， Perugino CA，et al. Clinical phenotypes of IgG4-related disease：An analysis of two international cross-sectional cohorts[J]. Ann Rheum Dis， 2019， 78（3）：406-412. DOI： 10.1136/annrheumdis-2018-214603.
|
| [18] |
Carballo I， Gonzalez-Quintela A， Sopena B，et al. Immunoglobulin G4-related disease：What an allergist should know[J]. J Investig Allergol Clin Immunol， 2021， 31（3）：212-227. DOI： 10.18176/jiaci.0633.
|
| [19] |
Berti A， Della-Torre E， Gallivanone F，et al. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease[J]. Rheumatology （Oxford）， 2017， 56（12）：2084-2092. DOI： 10.1093/rheumatology/kex234.
|
| [20] |
Umehara H， Okazaki K， Masaki Y，et al. Comprehensive diagnostic criteria for IgG4-related disease（IgG4-RD），2011[J]. Mod Rheumatol， 2012， 22（1）：21-30. DOI： 10.1007/s10165-011-0571-z.
|
| [21] |
Varghese JL， Fung AWS， Mattman A，et al. Clinical utility of serum IgG4 measurement[J]. Clin Chim Acta， 2020， 506：228-235. DOI： 10.1016/j.cca.2020.04.001.
|
| [22] |
Umehara H， Okazaki K， Kawano M，et al. How to diagnose IgG4-related disease[J]. Annals of the rheumatic diseases， 2017， 76（11）：e46. DOI： 10.1136/annrheumdis-2017-211330.
|
| [23] |
Wallace ZS， Naden RP， Chari S，et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease[J]. Ann Rheum Dis， 2020， 79（1）：77-87. DOI： 10.1136/annrheumdis-2019-216561.
|
| [24] |
|
| [25] |
Yamamoto M， Harada S， Ohara M，et al. Clinical and pathological differences between Mikulicz′s disease and Sjögren′s syndrome[J]. Rheumatology（Oxford）， 2005， 44（2）：227-234. DOI： 10.1093/rheumatology/keh447.
|
| [26] |
Kamiński B， Błochowiak K. Mikulicz′s disease and Küttner′s tumor as manifestations of IgG4-related diseases：A review of the literature[J]. Reumatologia， 2020， 58（4）：243-250. DOI： 10.5114/reum.2020.98437.
|
| [27] |
Kamiński B. Mikulicz′s disease and Sjögren′s syndrome as the main autoimmune disorders involving salivary glands[J]. Medical Studies/Studia Medyczne， 2020， 36（3）：211-218. DOI： 10.5114/ms.2020.99545.
|
| [28] |
Baba D， Sotome K， Maeda I，et al. A case report of Kuttner tumor mimicking a malignant tumor，leading to overtreatment[J]. Clin Case Rep， 2021， 9（5）：e04120. DOI： 10.1002/ccr3.4120.
|
| [29] |
Khurram SA， Fernando M， Smith AT，et al. IgG4-related sclerosing disease clinically mimicking oral squamous cell carcinoma[J]. Oral Surg Oral Med Oral Pathol Oral Radiol， 2013， 115（2）：e48-e51. DOI： 10.1016/j.oooo.2012.04.011.
|
| [30] |
Gontarz M， Wyszyńska-Pawelec G， Zapała J，et al. IgG4-related disease in the head and neck region：Report of two cases and review of the literature[J]. Pol J Pathol， 2016， 67（4）：370-375. DOI： 10.5114/pjp.2016.65871.
|
| [31] |
Bukhari A， Magnuson B， Lerman MA. IgG4-related disease mimicking extranodal lymphoma of the hard palatal mucosa：A case report and review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol， 2018， 126（4）：e198. DOI： 10.1016/j.oooo.2018.05.022.
|
| [32] |
Al-Mujaini A， Al-Khabori M， Shenoy K，et al. Immunoglobulin G4-related disease：An update[J]. Oman Med J， 2018， 33（2）：97-103. DOI： 10.5001/omj.2018.20.
|
| [33] |
Khosroshahi A， Wallace ZS， Crowe JL，et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol， 2015， 67（7）：1688-1699. DOI： 10.1002/art.39132.
|
| [34] |
Iguchi T， Takaori K， Mii A，et al. Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease[J]. Mod Pathol， 2018， 31（6）：890-899. DOI： 10.1038/s41379-018-0036-4.
|
| [35] |
Wu Q， Chang J， Chen H，et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases：A preliminary randomized controlled trial[J]. Int J Rheum Dis， 2017， 20（5）：639-646. DOI： 10.1111/1756-185X.13088.
|
| [36] |
Zhao Z， Hua Z， Luo X，et al. Application and pharmacological mechanism of methotrexate in rheumatoid arthritis[J]. Biomed Pharmacother， 2022， 150：113074. DOI： 10.1016/j.biopha.2022.113074.
|
| [37] |
Yunyun F， Yu C， Panpan Z，et al. Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids[J]. Sci Rep， 2017， 7（1）：6195. DOI： 10.1038/s41598-017-06520-5.
|
| [38] |
Yunyun F， Yu P， Panpan Z，et al. Efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin G4-related disease：A randomized clinical trial[J]. Rheumatology （Oxford）， 2019， 58（1）：52-60. DOI： 10.1093/rheumatology/key227.
|
| [39] |
Carruthers MN， Topazian MD， Khosroshahi A，et al. Rituximab for IgG4-related disease：A prospective，open-label trial[J]. Ann Rheum Dis， 2015， 74（6）：1171-1177. DOI： 10.1136/annrheumdis-2014-206605.
|
| [40] |
Omar D， Chen Y， Cong Y，et al. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD：A systematic review and network meta-analysis[J]. Rheumatology（Oxford）， 2020， 59（4）：718-726. DOI： 10.1093/rheumatology/kez380.
|
| [41] |
|
| [42] |
|